SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Remedy Taking a hit why?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas DeGagne who wrote (755)1/28/2001 11:40:27 AM
From: Qualified Opinion  Read Replies (1) of 763
 
A few more points made during the earnings conference call>>>

Remedy increased its sales force by 30%, 370 salesmen on 1/25/01 versus 285 on 9/30/00. Many of the new sales reps. are from the competition. Remedy has 188 partners under contract. Remedy will be selling solutions by market segment. They can deliver solutions faster than their competition. This enables their customers to adapt quicker to a changing environment. They added 250 new customers during the quarter including Lam Research, Fiat, Nasdaq Japan, Lehman Brothers, Prudential Europe, Capital One, Zurich Bank, Northern States Power and Chicago Stock Exchange to name a few. Remedy has approximately $7 per share in cash on its Balance Sheet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext